Cargando…
Imaging tau pathology in Parkinsonisms
The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that testing also be performed in parkinsonian tauo...
Autores principales: | Coakeley, Sarah, Strafella, Antonio P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491530/ https://www.ncbi.nlm.nih.gov/pubmed/28685158 http://dx.doi.org/10.1038/s41531-017-0023-3 |
Ejemplares similares
-
Imaging pathological tau in atypical parkinsonisms: A review
por: Mena, Anastassia M., et al.
Publicado: (2022) -
Microglial activation in Parkinson’s disease using [(18)F]-FEPPA
por: Ghadery, Christine, et al.
Publicado: (2017) -
Imaging Impulsivity in Parkinson's Disease and the Contribution of the Subthalamic Nucleus
por: Ray, Nicola, et al.
Publicado: (2011) -
Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018) -
Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson’s Disease
por: Koshimori, Yuko, et al.
Publicado: (2016)